HE 2000

Drug Profile

HE 2000

Alternative Names: 16-Bromoepiandrosterone; Alpha-Epi-Br (HE2000) - Harbor BioSciences; Immunitin; Inactivin

Latest Information Update: 21 Feb 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Colthurst
  • Developer Cystic Fibrosis Foundation Therapeutics; Harbor Therapeutics; Hollis-Eden Pharmaceuticals
  • Class Androstanols; Antivirals; Small molecules
  • Mechanism of Action Enzyme inhibitors; HIV replication inhibitors; Immunomodulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Suspended Hepatitis B; Hepatitis C; HIV infections; Malaria; Tuberculosis
  • Discontinued Cystic fibrosis

Most Recent Events

  • 18 Jan 2011 HE 2000 licensed to China State Institute of Pharmaceutical Industry in China and Hong Kong
  • 06 Aug 2007 Suspended - Phase-II for Hepatitis B in Malaysia (unspecified route)
  • 06 Aug 2007 Suspended - Phase-II for Hepatitis B in Singapore (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top